Study of Echocardiographic Parameters In Covid 19 Patients [COVID-19]
Research type
Research Study
Full title
To evaluate clinical and echocardiographic parameters including RV strain in a cohort of patients with confirmed COVID-19 in order to establish if these measures confer incremental prognostic information in this group of hospitalised patients.
IRAS ID
284335
Contact name
Alexander Stockenhuber
Contact email
Sponsor organisation
Buckshealthcare NHS Trust
Duration of Study in the UK
0 years, 2 months, 31 days
Research summary
Coronavirus disease-2019 (COVID-19) is a rapidly spreading infectious disease which was declared a pandemic by the World Health Organization on March 11th 2020.\nCOVID-19 causes severe acute respiratory distress syndrome that has significant implications for the care of patients who have previous experienced problems with their heart.\nPatients with underlying cardiovascular disease, such as high blood pressure, have an increased risk of severe disease and death. The patients usually present with a raised troponin levels (approx. 22%), this is a cardiac marker found from a blood test, which indicates heart muscle death or damage.\n\nUsually this does not indicate blocked arteries that run through the heart in Covid 19 pateint population, but it due to other complications that affect the heart and this in these caese it is associated with worse outcomes.\nWhen patients require intubation/ventilation support and die it is mostly due to viral pneumonia complicated by ARDS and cytokine storm.\n•\tThere is good evidence for impaired RV function and pulmonary artery pressures on Echocardiography in ARDS as an early and reliable predictor of deterioration and outcome\n
REC name
N/A
REC reference
N/A